Editas Medicine Financial Overview
Editas Medicine's market cap is currently $213.78M. The company's EPS TTM is $-0.28; its P/E ratio is -0.92; Editas Medicine is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
